Adastra Pharmaceuticals

About:

Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.

Top Investors: Mitsubishi Motors, Mitsubishi Electric, Morgenthaler Ventures, Domain Associates, Oxford Bioscience Partners

Description:

Adastra Pharmaceuticals is a private clinical-stage oncology company that provides responsible solutions to advance patient care in oncology. It develops pharmaceutical proprietary medicines for the treatment of various cancers. The company's medicines include an oral multi-kinase inhibitor which combines the benefits of inhibiting important cyclin-dependent kinases equipotently, enabling healthcare professional to ensure better survival of their patients. Adastra Pharmaceuticals was founded in 2005 and is headquartered in San Diego, California.

Total Funding Amount:

$85M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2005-01-01

Contact Email:

cmiller(AT)tragarapharma.com

Founders:

Christopher LeMasters

Number of Employees:

11-50

Last Funding Date:

2016-11-15

IPO Status:

Private

Industries: